Patni Life Sciences Veteran to Speak at DIA Annual Meeting

Business Wire, June 9, 2008

Patni VP Steve Jolley Joins FDA Leader to co-present on Pharmacovigilance and Risk Assessment at June 22 Event

BOSTON -- Patni Computer Systems (NYSE: PTI), a leading global IT services provider, today announced that Steve T. Jolley, Vice President of Pharmacovigilance at Patni Life Sciences, will co-present with Carol L. Krueger, BSN, RN, with the FDA's Surveillance Programs Team, at the U.S. Food & Drug Administration, at the Drug Information Association's 44th Annual Meeting on June 22 - 25 in Boston.

Jolley and Krueger will present a tutorial on "Pharmacovigilance Assessment and Risk Management: Essential Components to Good Pharmacovigilance Practice". The session, designed for professionals working in pharmacovigilance and drug safety, clinical research and regulatory affairs, is scheduled to run from 8:30 a.m. to noon at the Boston Convention and Exhibition Center.

Jolley is Patni's subject matter expert in all areas of pharmacovigilance, with responsibility for developing and delivering solutions surrounding pharmacovigilance-related policies, processes, systems and infrastructure. He has more than 20 years experience in the pharmaceutical arena.

"As pharmaceutical companies face an increasingly complex set of international regulations, demonstrating commitment to Good Pharmacovigilance Practice is essential to drug development and commercialization," Jolley said. "Those who perform thorough assessments, develop pre- and post-market risk surveillance programs, and keep up with updates to existing government guidances and regulations will position themselves for success in this challenging market."

Jolley, who is active in pharmaceutical industry forums, participated in a "think tank" meeting on Pharmacovigilance and data mining involving 60 select industry leaders last week at the Universities at Shady Grove in Rockville, MD. The workshop, "Best Practices in Pharmacovigilance: Developing Standards for Data Mining," was organized by the Center for Drugs and Public Policy at the University of Maryland School of Pharmacy. Professionals from academia, industry, government and regulatory agencies were selected because of their expertise and ongoing involvement in data mining.

About Patni

Patni Computer Systems Limited (BSE: PATNI COMPUT, NSE: PATNI, NYSE: PTI) is a global provider of IT Services and business solutions, servicing Global 2000 clients. Patni caters to its clients through its industry-focused practices, including insurance, financial services, manufacturing, life sciences, telecommunications and media & entertainment, and its technology-focused practices.

With an employee strength of over 15,000; multiple global delivery centres spread across 11 cities worldwide; 22 international offices across the Americas, Europe and Asia-Pacific; Patni has registered revenues of US$ 663 million for the year 2007. Patni's service offerings include application development and maintenance, enterprise application solutions, business and technology consulting, product engineering services, infrastructure management services, customer interaction services & business process outsourcing, quality assurance and engineering services.

Committed to quality, Patni adds value to its client's businesses through well-established and structured methodologies, tools and techniques. Patni is an ISO 9001: 2000 certified and SEI-CMMI Level 5 (V 1.2) organization, assessed enterprise wide at P-CMM Level 3. In keeping with its focus on continuous process improvements, Patni adopts Six Sigma practices as an integral part of its quality and process frameworks.

For more information on Patni, visit www.patni.com.